Emergent BioSolutions (EBS) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Earnings Preview: EBS to Report Financial Results Post-market on March 03
Moomoo NewsFeb 25 20:00 ET
Emergent BioSolutions Inc. (NYSE:EBS) Looks Inexpensive After Falling 33% But Perhaps Not Attractive Enough
Simply Wall StFeb 22 07:44 ET
Deregulation Exposure Was the Most Valuable Characteristic of a Stock Owned by Hedge Funds – GS
Seeking AlphaFeb 21 11:22 ET
Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
GlobeNewswireFeb 18 08:55 ET
10 Health Care Stocks With Whale Alerts In Today's Session
BenzingaFeb 12 12:35 ET
Is Emergent BioSolutions (NYSE:EBS) Using Too Much Debt?
Simply Wall StFeb 12 05:47 ET

Comments

152296745

Feb 20 15:17

$Emergent BioSolutions (EBS.US)$
The price will up soon！

2

Trytosaveabit

Feb 7 07:09

Hmm

$Emergent BioSolutions (EBS.US)$ Emergent BioSolutions and Pro Football Legend Emmitt Smith Raise Awareness of Ready to Rescue Campaign Timed to the Big Game in New Orleans
1 MINUTE AGO, 8:06 AM EST
VIA GLOBENEWSWIRE
Despite the recently reported national decline in opioid overdose deaths, many U.S. communities, including New Orleans, continue to see an increase in accidental drug-related deaths year over year
The ‘Lay, Spray, Stay' opioid overdose educational video featuring Smith and how to ...

2

Jaguar8

Jan 14 21:45

🔴 Watchlist JANUARY 15,2025, Wednesday. NFA. I won’t be around tomorrow morning.

NOTE!
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If yo...

88

27

3

Jaguar8

Jan 14 06:36

NEWS

$Emergent BioSolutions (EBS.US)$
Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals
Emergent BioSolutions (NYSE: EBS) has secured exclusive commercial rights to KLOXXADO® (naloxone HCl) Nasal Spray in the U.S. and Canada from Hikma Pharmaceuticals through a six-year agreement. This 8 mg naloxone product complements EBS's existing NARCAN® Nasal Spray 4 mg, expanding their portfolio of opioid overdose emergency treatments.
...

Trytosaveabit

Jan 14 06:34

News

$Emergent BioSolutions (EBS.US)$ Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals
2 MINUTES AGO, 7:30 AM EST
VIA GLOBENEWSWIRE
Alongside over-the-counter NARCAN® Nasal Spray 4 mg, prescription KLOXXADO® (naloxone HCl) Nasal Spray 8 mg will expand Emergent's ability to distribute multiple life-saving opioid overdose emergency treatments to patients, customers and communities in need
Focus remains on increasing access, ra...

1

EBS Emergent BioSolutions

Trade Overview

Capital Trend

News

Comments

Trending Stocks